“Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study”, J of Skin, vol. 7, no. 2, p. s109, Mar. 2023, doi: 10.25251/skin.7.supp.109.